MedTrace Logo

Extended Depth of Focus Contact Lenses for Presbyopia

NCT05495971 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-12-16

Study results available
· View outcomes & findings →

Summary

VTI has an FDA cleared soft contact lens product. Its optical design creates an enhanced depth of focus (EDOF), which provides clear distance, intermediate, and near vision. This study is to quantify the enhanced depth of focus and visual impact.

Conditions

Interventions

DEVICE

NaturalVue Multifocal

EDOF

Sponsors & Collaborators

  • Visioneering Technologies, Inc

    lead INDUSTRY

Principal Investigators

  • Douglas P. Benoit, OD · Visioneering Technologies, Inc

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-06
Primary Completion
2023-05-12
Completion
2023-05-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05495971 on ClinicalTrials.gov